Correction: Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer

Correction: Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer

Saved in:

Bibliographic Details
Main Authors:	Zhixuan Wu, Haoyi Xiang, Xiaowu Wang, Rongrong Zhang, Yangyang Guo, Liangchen Qu, Jingyao Zhou, Yanyi Xiao
Format:	Article
Language:	English
Published:	BMC 2025-04-01
Series:	Molecular Medicine
Online Access:	https://doi.org/10.1186/s10020-025-01188-4
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer
by: Zhixuan Wu, et al.
Published: (2024-09-01)

Author Correction: Development and validation of a prognostic signature of breast cancer based on drug absorption, distribution, metabolism and excretion (ADME)-related genes
by: Zhixuan Wu, et al.
Published: (2024-12-01)

Network Pharmacology, Molecular Docking, and Molecular Dynamics Analysis of Honokiol against Triple-negative Breast Cancer
by: Hassan H. Alhassan
Published: (2024-12-01)

Network Pharmacology, Molecular Docking and Experimental Verification to Explore the Mechanism of Chicoric Acid against Hepatocellular Carcinoma
by: Wenqian XU, et al.
Published: (2025-09-01)

Exploring the Mechanism of Wenshen Huatan Quyu Decotion for PCOS Based on Network Pharmacology and Molecular Docking Verification
by: Xin Guo, et al.
Published: (2022-01-01)

Pharmacological mechanisms of berberine against triple negative breast cancer: Integration of network pharmacology and experimental validation
by: Tian Qin, et al.
Published: (2025-08-01)

Investigating the Mechanism of the Fuzheng Huayu Formula in Treating Cirrhosis through Network Pharmacology, Molecular Docking, and Experimental Verification
by: Ruixue Yu, et al.
Published: (2025-04-01)

Retracted: Exploring the Mechanism of Wenshen Huatan Quyu Decotion for PCOS Based on Network Pharmacology and Molecular Docking Verification
by: Stem Cells International
Published: (2023-01-01)

Danhong Injection Inhibits Apoptosis in Ischemia/Reperfusion Injury Based on Network Pharmacology Analysis, Molecular Docking, and Experimental Verification
by: Shennan Shi, et al.
Published: (2025-02-01)

Unveiling the Mechanisms and Therapeutic Effects of Xiaoyao Sanjie Decoction in Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Approach
by: Qi Y, et al.
Published: (2024-12-01)

Stromal PLAU mediates tumor progression and informs a novel therapeutic target in triple-negative breast cancer
by: Jun Zou, et al.
Published: (2025-07-01)

Development and verification of a novel risk model related to ubiquitination linked with prognosis and therapeutic response in clear cell renal cell carcinoma
by: Yingzhi Chen, et al.
Published: (2024-10-01)

Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
by: Chang Cheng, et al.
Published: (2025-01-01)

Integrating network pharmacology and experimental verification to explore the protective effects of Evodia rutaecarpa in ischemic stroke.
by: Zhixuan Huang, et al.
Published: (2025-01-01)

Nomogram for the prediction of the prognosis of patients with triple-negative invasive ductal carcinoma of breast after neoadjuvant chemotherapy
by: Qiuyu Yang, et al.
Published: (2025-07-01)

Combining network pharmacology, molecular docking, and experimental verification to investigate the anti-rheumatoid arthritis effect and mechanism of Baeckea frutescens leaves
by: Xueyang Guo, et al.
Published: (2025-07-01)

Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC
by: He Geng, et al.
Published: (2024-12-01)

Exploring Cannabidiol’s Therapeutic Role in Colorectal Cancer: Network Pharmacology and Molecular Docking Insights
by: Juan Manuel Guzmán-Flores, et al.
Published: (2025-02-01)

A Preliminary Study on the Therapeutic Role of γδT Cells in Triple‐Negative Breast Cancer
by: Shi Qiu, et al.
Published: (2025-08-01)

Cybertoxicology, molecular docking, and experimental verification reveal the mechanism of action of chlorpyrifos on skin damage
by: Weibin Du, et al.
Published: (2025-01-01)

Integrating network pharmacology, molecular docking, and experimental verification to demonstrate that Jiawei Duhuo Parasitic Decoction treated osteoarthritis by inhibiting PTGS2 expression
by: Yang Duan, et al.
Published: (2025-06-01)

Mechanism of the Proprietary Chinese Medicine “JiuLiWan” to Treat Ulcerative Colitis Revealed by Network Pharmacology, Molecular Docking, and Experimental Verification In Vitro
by: Zhifang Liao, et al.
Published: (2025-05-01)

The role of CAFs in therapeutic resistance in triple negative breast cancer: an emerging challenge
by: Marianna Rita Brogna, et al.
Published: (2025-03-01)

Exploring Novel Therapeutic Targets in Breast Cancer via Comprehensive Omics Profiling and Experimental Verification
by: Shengjun Chai, et al.
Published: (2025-04-01)

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
by: Wen-yu Cai, et al.
Published: (2025-02-01)

Exploring the therapeutic potential and in vitro validation of baicalin for the treatment of triple-negative breast cancer
by: Yuan Ma, et al.
Published: (2025-04-01)

Unveiling Isorhapontigenin’s therapeutic potential in lung cancer via integrated network pharmacology, molecular docking, and experimental validation
by: Zhiyu Wu, et al.
Published: (2025-05-01)

Exploring the therapeutic mechanism of itraconazole combined with ritonavir on Candida albicans infection through network pharmacology and molecular docking
by: Yiyang Feng, et al.
Published: (2025-07-01)

Mechanisms Underlying the Therapeutic Effects of Brucea javanica in Cervical Cancer Treatment Based on Network Pharmacology and Molecular Docking
by: Wen Jin, et al.
Published: (2025-01-01)

Multi - dimensional mechanism analysis of Choerospondias axillaris (Roxb.) Burtt et Hill in treating kidney stones: network pharmacology, molecular docking and in vitro experimental verification
by: Meiqi Qiu, et al.
Published: (2025-04-01)

Triple-Negative Breast Cancer
by: Quyen D. Chu, et al.
Published: (2012-01-01)

Decoding the therapeutic mechanism of Conocarpus lancifolius in hepatocellular carcinoma: network pharmacology, molecular docking, and LC-MS QTOF insights
by: Poojaben M. Prajapati, et al.
Published: (2025-06-01)

Identification of Therapeutic Potential of Hydroxychavicol Against Alzheimer’s Disease: An Integrated Network Pharmacology, Molecular Docking, and Dynamic Simulation Study
by: Priyank Upadhayay, et al.
Published: (2025-01-01)

ITGA4 Contributes to 5-Fluorouracil Resistance by Up-Regulating PI3K/AKT Signaling: Evidence from Network Pharmacology, Molecular Docking and Experimental Verification
by: Yan S, et al.
Published: (2025-05-01)

Huangkui capsule combined with finerenone attenuates diabetic nephropathy by regulating the JAK2/STAT3 signaling pathway based on network pharmacology, molecular docking, and experimental verification
by: Xuanke Liu, et al.
Published: (2025-08-01)

Delineation of the Germline and Somatic Mutation Interaction Landscape in Triple-Negative and Non-Triple-Negative Breast Cancer
by: Jiande Wu, et al.
Published: (2020-01-01)

Correction: Network pharmacology combined with experimental verification for exploring the potential mechanism of phellodendrine against depression
by: Lili Hu, et al.
Published: (2025-06-01)

Exploring the potential pharmacological mechanism of aripiprazole against hyperprolactinemia based on network pharmacology and molecular docking
by: Lei Yang, et al.
Published: (2024-11-01)

Network Pharmacology and Molecular Docking Analysis of Chrysoeriol for Alzheimer’s Disease
by: D Hariharasudhan, et al.
Published: (2025-01-01)

TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER
by: A. D. Zikiryakhodzhaev, et al.
Published: (2017-06-01)